# TAPENTADOL
> **ANDA206418** · Abbreviated New Drug Application (Generic) · Sponsor: WEST-WARD PHARMS INT · Approved 2026-02-13
## Drug
- **FDA Application Number:** ANDA206418
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TAPENTADOL
- **Generic name:** Tapentadol
- **Active ingredients:** TAPENTADOL
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** WEST-WARD PHARMS INT
- **First approval:** 2026-02-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206418)
---
*MORVS · CC0 1.0*